Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.
Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.
December 30, 2021
by PharmaSources.com
Workshop on Antimicrobial Resistance organised in S Korea
Centrient Pharmaceuticals, a global leader in sustainable antibiotics manufacturing, in partnership with Indian Institute of Technology – Delhi, organised a workshop on ‘Sustainability Through Excellence in Manufacturing’ (STEM) in Seoul today.
December 2, 2019
by expresspharma
2019 China Cancer Immunotherapy Workshop Successfully Held
2019 China Cancer Immunotherapy Workshop was successfully held on June 29- 30, 2019 in Tianjin, China. The Workshop was organized by China Center for Food and Drug International Exchange(CCFDIE) ...
July 23, 2019
by chinadaily
DIA – CMC Workshop
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena.
May 15, 2018
by pharmafile
‘Computer System Validation’ workshop to be held in Mumbai
CPhI Conferences through this workshop will offer professionals from the pharma industry an understanding of regulatory requirements and risk-based approach under GAMP5 guidelines
October 16, 2017
by expressbpd